What is Tvardi Therapeutics, Inc. Common Stock's Market Cap?

Tvardi Therapeutics, Inc. Common Stock's Market Cap is $25.9M, based on as-reported figures from SEC (XBRL) filings.

What is Tvardi Therapeutics, Inc. Common Stock's Enterprise Value?

Tvardi Therapeutics, Inc. Common Stock's Enterprise Value is $10.1M, based on as-reported figures from SEC (XBRL) filings.

What is Tvardi Therapeutics, Inc. Common Stock's EV / EBITDA?

Tvardi Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Tvardi Therapeutics, Inc. Common Stock's Net Income (TTM)?

Tvardi Therapeutics, Inc. Common Stock's Net Income (TTM) is -$26.1M, based on as-reported figures from SEC (XBRL) filings.

What is Tvardi Therapeutics, Inc. Common Stock's EBITDA?

Tvardi Therapeutics, Inc. Common Stock's EBITDA is -$27.1M, based on as-reported figures from SEC (XBRL) filings.

What is Tvardi Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Tvardi Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.95, based on as-reported figures from SEC (XBRL) filings.

What is Tvardi Therapeutics, Inc. Common Stock's Net Debt?

Tvardi Therapeutics, Inc. Common Stock's Net Debt is -$15.8M, based on as-reported figures from SEC (XBRL) filings.

Tvardi Therapeutics, Inc. Common Stock (TVRD) Financial Statements

Tvardi Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V0GHL4

XNAS · usd

1.94▲ 0.03 (1.57%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.91

Day's Range1.87 – 1.96

52-Week Range1.50 – 43.65

Volume162.7K

Avg Volume218.7K

Share Statistics

Shares Outstanding

Employees12

ExchangeXNAS

Listed2025-04-16

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Tvardi Therapeutics, Inc. Common Stock (TVRD)

What is Tvardi Therapeutics, Inc. Common Stock's Market Cap?: Tvardi Therapeutics, Inc. Common Stock's Market Cap is $25.9M, based on as-reported figures from SEC (XBRL) filings.
What is Tvardi Therapeutics, Inc. Common Stock's Enterprise Value?: Tvardi Therapeutics, Inc. Common Stock's Enterprise Value is $10.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tvardi Therapeutics, Inc. Common Stock's EV / EBITDA?: Tvardi Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tvardi Therapeutics, Inc. Common Stock's Net Income (TTM)?: Tvardi Therapeutics, Inc. Common Stock's Net Income (TTM) is -$26.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tvardi Therapeutics, Inc. Common Stock's EBITDA?: Tvardi Therapeutics, Inc. Common Stock's EBITDA is -$27.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tvardi Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Tvardi Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.95, based on as-reported figures from SEC (XBRL) filings.
What is Tvardi Therapeutics, Inc. Common Stock's Net Debt?: Tvardi Therapeutics, Inc. Common Stock's Net Debt is -$15.8M, based on as-reported figures from SEC (XBRL) filings.